Date | Speaker | Title | Time starts | Duration |
November 2015 | Chris Kosmidis | Isavuconazole: a new antifungal drug | 0’00’00secs | 0’36’40secs |
Graham Atherton | Patients and carers disucssion | 0’36’40secs | end | |
Led by Graham Atherton | Entire meeting (alternate version) |
We had to switch off the discussion with patients after Chris & Graham’s introduction ending at 36min 40sec as the group had to proceed privately. The slides discussed give a good deal of the information we talked about so are well worth reading once the talking has stopped.
Resources mentioned:
Share this post
Latest News posts
ISHAM Award for Prof Malcolm Richardson
September 28, 2022
Why does someone with chronic disease feel so tired?
August 8, 2022
The importance of detecting cancer early
July 8, 2022
Fungal Infection Trust
July 5, 2022
Aspergillosis and Fatigue
June 20, 2022
Singing for lung health
May 24, 2022
Monkeypox outbreak
May 23, 2022
Drug Induced Photosensitivity
May 9, 2022
News archive
× Close
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video